OptimizeRx Corp (OPRX) stock
OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3026% below fair value
$7.31+0.37 (+5.33%)
Close on Nov 18, 2026Market cap $137.69MP/E 30.5Yield –
OptimizeRx shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
OptimizeRx's shares outstanding was 19M at Jun 30, 2026. For fiscal 2025 it was 19M, up 3.9% from the year before. Over ten years it grew 8.8% a year on average. The highest annual figure on record is 19M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 19M | +3.9% |
| FY2024 | Dec 31, 2024 | 18M | +6.8% |
| FY2023 | Dec 31, 2023 | 17M | -3.7% |
| FY2022 | Dec 31, 2022 | 18M | +0.5% |
| FY2021 | Dec 31, 2021 | 18M | +19.3% |
| FY2020 | Dec 31, 2020 | 15M | +10.8% |
| FY2019 | Dec 31, 2019 | 13M | +12.9% |
| FY2018 | Dec 31, 2018 | 12M | +20.8% |
| FY2017 | Dec 31, 2017 | 10M | -0.8% |
| FY2016 | Dec 31, 2016 | 10M | +20.9% |
| FY2015 | Dec 31, 2015 | 8M | +2.3% |
| FY2014 | Dec 31, 2014 | 8M | +13.3% |
| FY2013 | Dec 31, 2013 | 7M | +23.2% |
| FY2012 | Dec 31, 2012 | 6M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 19M | -1.2% |
| Q1 FY2026 | Mar 31, 2026 | 19M | +1.6% |
| Q4 FY2025 | Dec 31, 2025 | 19M | +2.8% |
| Q3 FY2025 | Sep 30, 2025 | 19M | +6.2% |
| Q2 FY2025 | Jun 30, 2025 | 19M | +4.1% |
| Q1 FY2025 | Mar 31, 2025 | 18M | +1.7% |
| Q4 FY2024 | Dec 31, 2024 | 18M | +3.6% |
| Q3 FY2024 | Sep 30, 2024 | 18M | +10.1% |
| Q2 FY2024 | Jun 30, 2024 | 18M | +7.4% |
| Q1 FY2024 | Mar 31, 2024 | 18M | +6.3% |
| Q4 FY2023 | Dec 31, 2023 | 18M | +3.6% |
| Q3 FY2023 | Sep 30, 2023 | 17M | -6.9% |
| Q2 FY2023 | Jun 30, 2023 | 17M | -13.6% |
| Q1 FY2023 | Mar 31, 2023 | 17M | -6.1% |
| Q4 FY2022 | Dec 31, 2022 | 17M | -5.3% |
| Q1 FY2022 | Mar 31, 2022 | 18M | +11.0% |
| Q4 FY2021 | Dec 31, 2021 | 20M | +30.0% |
| Q3 FY2021 | Sep 30, 2021 | 18M | +22.1% |
| Q2 FY2021 | Jun 30, 2021 | 18M | +23.4% |
| Q1 FY2021 | Mar 31, 2021 | 16M | +10.2% |
| Q4 FY2020 | Dec 31, 2020 | 15M | +9.6% |
| Q3 FY2020 | Sep 30, 2020 | 15M | +13.9% |
| Q2 FY2020 | Jun 30, 2020 | 15M | +20.7% |
| Q1 FY2020 | Mar 31, 2020 | 15M | +13.1% |
| Q2 FY2019 | Jun 30, 2019 | 14M | +15.5% |
| Q1 FY2019 | Mar 31, 2019 | 13M | +33.6% |
| Q4 FY2018 | Dec 31, 2018 | 12M | +24.5% |
| Q3 FY2018 | Sep 30, 2018 | 13M | +32.5% |
| Q2 FY2018 | Jun 30, 2018 | 12M | +21.2% |
| Q1 FY2018 | Mar 31, 2018 | 10M | -1.2% |
| Q4 FY2017 | Dec 31, 2017 | 10M | -4.6% |
| Q3 FY2017 | Sep 30, 2017 | 10M | -0.6% |
| Q2 FY2017 | Jun 30, 2017 | 10M | +1.5% |
| Q1 FY2017 | Mar 31, 2017 | 10M | +2.4% |
| Q4 FY2016 | Dec 31, 2016 | 10M | – |
| Q3 FY2016 | Sep 30, 2016 | 10M | – |
| Q2 FY2016 | Jun 30, 2016 | 10M | – |
| Q1 FY2016 | Mar 31, 2016 | 10M | – |
See a number that looks wrong?